Of all the subtypes, notably, CTNNB1-mutated HCC with activating WNT/β-catenin pathway has a well-differentiated tumor phenotype and lacks immune cell infiltration (Figure 2). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.